Annals of thoracic surgery short reports · 2025
Impact of Collateral Vessels on Fontan Circulation: 0- to 1-Dimensional Fontan Circulation Model and Concept of Oxygen Supply and Consumption.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sughimoto Koichi, Miki Toru, Li Ruichen, Maeda Kenshu, Koda Daiki, Fujiwara Takashi, Liu Hao
Аннотация
BACKGROUND: Patients with single ventricle often undergo the Fontan operation to alleviate cyanosis and reduce ventricle volume load. However, long-term outcomes are limited by complications and hemodynamic issues, including collateral vessels, leading to cyanosis and heart failure. Studies have demonstrated considerable blood flow through these collateral vessels; however, their hemodynamic impact on Fontan circulation remains inadequately explained from a theoretical perspective. This study aims to clarify the effects of dobutamine and vasodilators on Fontan circulation in the presence of aortopulmonary collaterals (APCs) and venovenous collaterals (VVCs).
METHODS: A Fontan hemodynamic model incorporating VVC and APC was created. Scenarios were simulated by adjusting dobutamine dosage and oxygen delivery/consumption, predicting arterial and central venous oxygen saturations. Cardiac function was evaluated based on cardiac output, arterial elastance, ejection fraction, and stroke work to pressure-volume ratio.
RESULTS: Fontan circulations with VVC and APC had lower arterial and venous oxygen saturations (92% and 54%, respectively) compared with those without collaterals (96% and 62%, respectively). Decreased arterial elastance and increased stroke work to pressure-volume ratio indicated poor tissue perfusion. High pulmonary resistance decreased oxygen saturations and systemic blood flow, regardless of collaterals. Dobutamine (10 μg/kg/min) raised venous oxygen from 53% to 58%, respectively, in the presence of VVC and APC, but decreased arterial oxygen from 92% to 88%, respectively.
CONCLUSIONS: The results align with clinical findings, suggesting pulmonary vasodilators may improve oxygenation and perfusion in Fontan patients with collaterals. However, dobutamine effects are limited. Validation with actual patient data is needed to enhance model accuracy.
METHODS: A Fontan hemodynamic model incorporating VVC and APC was created. Scenarios were simulated by adjusting dobutamine dosage and oxygen delivery/consumption, predicting arterial and central venous oxygen saturations. Cardiac function was evaluated based on cardiac output, arterial elastance, ejection fraction, and stroke work to pressure-volume ratio.
RESULTS: Fontan circulations with VVC and APC had lower arterial and venous oxygen saturations (92% and 54%, respectively) compared with those without collaterals (96% and 62%, respectively). Decreased arterial elastance and increased stroke work to pressure-volume ratio indicated poor tissue perfusion. High pulmonary resistance decreased oxygen saturations and systemic blood flow, regardless of collaterals. Dobutamine (10 μg/kg/min) raised venous oxygen from 53% to 58%, respectively, in the presence of VVC and APC, but decreased arterial oxygen from 92% to 88%, respectively.
CONCLUSIONS: The results align with clinical findings, suggesting pulmonary vasodilators may improve oxygenation and perfusion in Fontan patients with collaterals. However, dobutamine effects are limited. Validation with actual patient data is needed to enhance model accuracy.